Development of interpretive criteria for tebipenem disk diffusion susceptibility testing with Staphylococcus spp. and Haemophilus influenzae

Author:

Fujisaki Momoko,Sadamoto Shinya,Ikedo Masanari,Totsuka Kyoichi,Kaku Mitsuo,Tateda Kazuhiro,Yamaguchi Keizo,Hirakata Yoichi

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference15 articles.

1. Pharmacological properties and clinical performance of the novel oral carbapenem antimicrobial drug, “Tebipenem pivoxil” (Orapenem® fine granules 10% for pediatric use);Sunakawa;Jpn J Chemother,2009

2. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement, M100-S19,2009

3. Performance standards for antimicrobial disk susceptibility tests. Approved standard, tenth edition, M02-A10,2009

4. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, eighth edition, M07-A8,2009

5. Development of in vitro susceptibility testing criteria and quality control parameters. Approved guideline, third edition, M23-A3,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3